New Briefs: January 2022

New Methods for Treating Difficult Cancers A new preclinical study led by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that treating people who have aggressive cancers, including melanoma, pancreatic and colorectal cancers, with immune checkpoint inhibitors, quickly followed by mutation-targeted therapy, can help overcome treatment resistance and help people live longer. Immune checkpoint inhibitors, […]

Tags: , , , , , , , , , , , , , , , , , ,
Enter Your Login Credentials
This setting should only be used on your home or work computer.

×